© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
ISSUU
In this essay, a long-term HIV survivor links past AIDS activism to current efforts to prevent gun violence.
During AIDSWatch 2018, HIV advocates visit Capitol Hill to lobby for the needs of people living with and at risk for HIV. [VIDEO]
A collection of art showcases the powerful bond between us and our pets.
Our June cover story links past AIDS activism to current efforts to prevent gun violence.
After nearly two decades, the Black AIDS Institute faces the future with new leadership and expanded services.
Advocates want the conference relocated.
A heart-wrenching POZ Stories installment
Robert R. Redfield, MD, is a longtime HIV researcher. But he’s also controversial.
In After Louie, Alan Cumming is an older AIDS activist with issues.
AIDS United calls out actions by the Trump administration that have harmed people living with HIV and LGBT people.
POZ deputy editor Trent Straube interviews John-Manuel Andriote about his latest book, “Stonewall Strong.”
Here are some important dates in AIDS history.
HIV testing news pops up in our social media feeds.
Merck’s investigational antiretroviral could one day be dosed only weekly among HIV-negative humans.
This long-acting drug is linked to undetectable viral loads in former prisoners with substance use disorders.
Scientists tested the effects of the broadly neutralizing antibody PGT121 and the immune-stimulating agent GS-9620 in monkeys.
The CDC reports that PrEP use is low among Blacks and Latinos.
The Food and Drug Administration approves antibody treatment Trogarzo for multidrug-resistant HIV.
An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.
The newly approved single-tablet regimen contains the integrase inhibitor bictegravir plus emtricitabine and tenofovir alafenamide.
People who have a low CD4 count, have cirrhosis and take certain hep C drug regimens are less likely to be cured.
AIDS activist and author Sarah Schulman explores HIV criminalization in “Conflict Is Not Abuse.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.